Procaps Group, S.A ROA 2020-2023 | PROCF
Current and historical return on assets (ROA) values for Procaps Group, S.A (PROCF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Procaps Group, S.A ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-09-30 |
$0.05B |
$0.50B |
10.99% |
| 2023-06-30 |
$0.07B |
$0.49B |
14.38% |
| 2023-03-31 |
$0.03B |
$0.44B |
7.16% |
| 2022-12-31 |
$0.04B |
$0.46B |
8.92% |
| 2022-09-30 |
$0.06B |
$0.47B |
12.73% |
| 2022-06-30 |
$-0.07B |
$0.47B |
-15.74% |
| 2022-03-31 |
$-0.07B |
$0.48B |
-17.58% |
| 2021-12-31 |
$-0.10B |
$0.46B |
-31.91% |
| 2021-09-30 |
$-0.14B |
$0.47B |
-46.39% |
| 2021-06-30 |
$-0.03B |
$0.14B |
-11.10% |
| 2021-03-31 |
$-0.03B |
$0.20B |
-11.58% |
| 2020-12-31 |
$-0.01B |
$0.36B |
-3.72% |
| 2020-09-30 |
$-0.01B |
$0.20B |
-2.47% |
| 2019-12-31 |
$-0.00B |
$0.20B |
-3.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
